Skip Navigation
National Cancer Institute
National Cancer Institute U.S. National Institutes of Health National Cancer Institute
OverviewProgramsAccomplishmentsEvent ListingNews and HighlightsPublished Research

Past Program Awardees

On September 13, 2004, the National Cancer Institute (NCI) announced a major commitment to develop and apply nanotechnology to cancer research. To carry out this initiative, the NCI, formed the NCI Alliance for Nanotechnology in Cancer, a comprehensive, integrated initiative encompassing researchers, clinicians, and public and private organizations, to develop and translate cancer-related nanotechnology research into clinical practice.

Initial focus for this research was in the areas of:

  • Molecular imaging and early detection
  • In vivo nanotechnology imaging systems
  • Reporters of efficacy
  • Multifunctional therapeutics
  • Prevention and control
  • Research enablers

Follow the links below to view the past program awardees:

Centers of Cancer Nanotechnology Excellence (2005-2010)
Cancer Nanotechnology Platform Partnerships (2005-2010)
Multidisciplinary Research Training and Team Development (2005-2010)

Centers of Cancer Nanotechnology Excellence (2005-2010)

  • Carolina Center of Cancer Nanotechnology Excellence
    University of North Carolina
    Principal Investigator: Rudolph Juliano, Ph.D.

  • Center for Cancer Nanotechnology Excellence Focused on Therapy Response
    Stanford University
    Principal Investigator: Sanjiv Sam Gambhir, M.D., Ph.D.

  • Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer (NANO-TUMOR)
    University of California, San Diego
    Principal Investigator: Sadik Esener, Ph.D.

  • Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology
    Emory University and Georgia Institute of Technology
    Principal Investigators: Shuming Nie, Ph.D.

  • MIT-Harvard Center of Cancer Nanotechnology Excellence
    MIT and Harvard University, Massachusetts General Hospital
    Principal Investigators: Robert Langer, Ph.D., and Ralph Weissleder, M.D., Ph.D.

  • Nanomaterials for Cancer Diagnostics and Therapeutics
    Northwestern University
    Principal Investigator: Chad Mirkin, Ph.D.

  • Nanosystems Biology Cancer Center (NSBCC)
    California Institute of Technology
    Principal Investigator: James Heath, Ph.D.

  • The Siteman Center of Cancer Nanotechnology Excellence
    Washington University
    Principal Investigator: Samuel Wickline, M.D.

Cancer Nanotechnology Platform Partnerships (2005-2010)

  • Detecting Cancer Early with Targeted Nano-probes for Vascular Signatures
    University of California
    Principal Investigator: Douglas Hanahan, Ph.D.

  • DNA-linked Dendrimer Nanoparticle Systems for Cancer Diagnosis and Treatment
    University of Michigan
    Principal Investigator: James Baker Jr., M.D.

  • Hybrid Nanoparticles in Imaging and Therapy of Prostate Cancer
    University of Missouri
    Principal Investigator: Kattesh Katti, Ph.D.

  • Integrated System for Cancer Biomarker Detection
    Massachusetts Institute of Technology
    Principal Investigator: Scott Manalis, Ph.D.

  • Metallofullerene Nanoplatform for Imaging and Treating Infiltrative Tumor
    Virginia Commonwealth University
    Principal Investigator: Panos Fatouros, Ph.D.

  • Multifunctional Nanoparticles in Diagnosis and Therapy of Pancreatic Cancer
    State University of New York
    Principal Investigator: Paras Prasad, Ph.D.

  • Nanotechnology Platform for Pediatric Brain Cancer Imaging and Therapy
    University of Washington
    Principal Investigator: Miqin Zhang, Ph.D.

  • Nanotechnology Platform for Targeting Solid Tumors
    The Sidney Kimmel Cancer Center
    Principal Investigator: Jan Schnitzer, M.D.

  • Nanotherapeutic Strategy for Multidrug Resistant Tumors
    Northeastern University
    Principal Investigator: Mansoor Amiji, Ph.D.

  • Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging
    The University of Texas M. D. Anderson Cancer Center
    Principal Investigator: Chun Li, Ph.D.

  • Novel Cancer Nanotechnology Platforms for Photodynamic Therapy and Imaging
    Roswell Park Cancer Institute
    Principal Investigator: Ravindra K. Pandey, Ph.D.

  • Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer-Nanoparticle Conjugate
    Massachusetts General Hospital
    Principal Investigator: Tayyaba Hasan, Ph.D.

Multidisciplinary Research Training and Team Development (2005-2010)

Multidisciplinary Research Training and Team Development Fellowship Awards were granted to the following postdoctoral trainees:

  • Design of Affinity Capture Agents for Akt1 Using in situ Click Chemistry, California Institute of Technology, Pasadena, CA
    Trainee: Steven W. Millward, Ph.D.

  • Geldanamycin-Mediated Uptake of Nanoparticle Probes, Purdue University, West Lafayette, Indiana
    Trainee: Giselle M. Knudsen, Ph.D.

  • Liposomal Delivery of High LET Emitters to Cell Nuclei, Johns Hopkins University, Baltimore, Maryland
    Trainee: Yah-El Har-El, Ph.D.

  • Nanolabels of Active Proteases for Cancer Detection, University of California, San Francisco, California
    Trainee: Mark D. Lim, Ph.D.

  • Nanoparticle-Bioconjugates as Cancer-Treating Agents, Texas A&M University, College Station, Texas
    Trainee: Sofi Bin-Salamon, Ph.D.

  • Nanoprobes and Integrated Nanodevices for Cancer Detection and Treatment, University of Colorado Health Services, Superior, CO
    Trainee: Wounjhang Park, Ph.D.

  • Nanoscale Mechanisms of Hsp90 and Its Co-chaperones, Yale University, New Haven, Connecticut
    Trainee: Ivo P. Doudevski, Ph.D.

  • Short-Interfering RNA-Gold Nanoparticle Bioconjugates: A New Cancer Therapy, Northwestern University, Evanston, Illinois
    Trainee: Adam B. Braunschweig, Ph.D.

  • Single Walled Carbon Nanotube Based Tumor Vaccines, Memorial Sloan-Kettering Institute for Cancer Research, New York, New York
    Trainee: Rena J. May, Ph.D.

  • Targeted Delivery Via Protein-Carbohydrate Interactions, Liquidia, Inc., Research Triangle Park, North Carolina
    Trainee: Ashley L. Galloway, Ph.D.

  • Targeted Photoactivated Nanopartcicles for the Treatment of Ovarian Cancer, Massachusetts General Hospital, Boston, MA
    Trainee: Daniel Neuman, Ph.D.

NCI-NSF Training Grants were awarded in 2005 to establish training programs for U.S. science and engineering doctoral students through the Integrative Graduate Education and Research Traineeship Program (IGERT). The awarded programs were:

  • Building Leadership for the Nanotechnology Workforce of Tomorrow, University of Washington
    Principal Investigator: Marjorie Olmstead, Ph.D.

  • Integrative Nanoscience and Microsystems, University of New Mexico
    Principal Investigator: Diana Huffaker, Ph.D.

  • Nanomedical Science and Technology, Northeastern University
    Principal Investigator: Srinivas Sridhar, Ph.D.

  • NanoPharmaceutical Engineering and Science, Rutgers University
    Principal Investigator: Fernando Muzzio, Ph.D.